Nasdaq:US$16.50 (+0.14) | HKEX:HK$26.00 (-0.10) | AIM:£2.70 (-0.01)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice